nodes	percent_of_prediction	percent_of_DWPC	metapath
Isradipine—Transient ischaemic attack—Sorafenib—liver cancer	0.0251	0.0396	CcSEcCtD
Isradipine—Oropharyngeal discomfort—Sorafenib—liver cancer	0.0174	0.0275	CcSEcCtD
Isradipine—Nimodipine—AHR—liver cancer	0.0144	0.385	CrCbGaD
Isradipine—Gynaecomastia—Sorafenib—liver cancer	0.0113	0.0179	CcSEcCtD
Isradipine—Cardiac failure—Sorafenib—liver cancer	0.00942	0.0149	CcSEcCtD
Isradipine—Pain in extremity—Sorafenib—liver cancer	0.00919	0.0145	CcSEcCtD
Isradipine—Breast disorder—Sorafenib—liver cancer	0.0083	0.0131	CcSEcCtD
Isradipine—Abdominal discomfort—Sorafenib—liver cancer	0.00761	0.012	CcSEcCtD
Isradipine—Erectile dysfunction—Sorafenib—liver cancer	0.00731	0.0116	CcSEcCtD
Isradipine—Acute coronary syndrome—Sorafenib—liver cancer	0.00698	0.011	CcSEcCtD
Isradipine—Myocardial infarction—Sorafenib—liver cancer	0.00694	0.011	CcSEcCtD
Isradipine—Hepatobiliary disease—Sorafenib—liver cancer	0.0067	0.0106	CcSEcCtD
Isradipine—Dermatitis atopic—Epirubicin—liver cancer	0.00632	0.00999	CcSEcCtD
Isradipine—Ventricular arrhythmia—Epirubicin—liver cancer	0.00632	0.00999	CcSEcCtD
Isradipine—Urinary tract disorder—Sorafenib—liver cancer	0.00628	0.00992	CcSEcCtD
Isradipine—Connective tissue disorder—Sorafenib—liver cancer	0.00625	0.00987	CcSEcCtD
Isradipine—Urethral disorder—Sorafenib—liver cancer	0.00623	0.00985	CcSEcCtD
Isradipine—Cardiac disorder—Sorafenib—liver cancer	0.0059	0.00932	CcSEcCtD
Isradipine—Flushing—Sorafenib—liver cancer	0.0059	0.00932	CcSEcCtD
Isradipine—Dermatitis atopic—Doxorubicin—liver cancer	0.00585	0.00924	CcSEcCtD
Isradipine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00585	0.00924	CcSEcCtD
Isradipine—Angiopathy—Sorafenib—liver cancer	0.00577	0.00911	CcSEcCtD
Isradipine—Immune system disorder—Sorafenib—liver cancer	0.00574	0.00907	CcSEcCtD
Isradipine—Mediastinal disorder—Sorafenib—liver cancer	0.00573	0.00905	CcSEcCtD
Isradipine—Mental disorder—Sorafenib—liver cancer	0.00557	0.0088	CcSEcCtD
Isradipine—Malnutrition—Sorafenib—liver cancer	0.00553	0.00874	CcSEcCtD
Isradipine—Muscle spasms—Sorafenib—liver cancer	0.00532	0.00841	CcSEcCtD
Isradipine—Anaemia—Sorafenib—liver cancer	0.00511	0.00808	CcSEcCtD
Isradipine—Angioedema—Sorafenib—liver cancer	0.00506	0.00799	CcSEcCtD
Isradipine—Nocturia—Epirubicin—liver cancer	0.00504	0.00797	CcSEcCtD
Isradipine—Syncope—Sorafenib—liver cancer	0.00496	0.00784	CcSEcCtD
Isradipine—Leukopenia—Sorafenib—liver cancer	0.00495	0.00783	CcSEcCtD
Isradipine—Clevidipine—CYP2E1—liver cancer	0.00488	0.131	CrCbGaD
Isradipine—Loss of consciousness—Sorafenib—liver cancer	0.00486	0.00769	CcSEcCtD
Isradipine—Cough—Sorafenib—liver cancer	0.00483	0.00763	CcSEcCtD
Isradipine—Arthralgia—Sorafenib—liver cancer	0.00471	0.00744	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00468	0.00739	CcSEcCtD
Isradipine—Nocturia—Doxorubicin—liver cancer	0.00467	0.00737	CcSEcCtD
Isradipine—Dry mouth—Sorafenib—liver cancer	0.00461	0.00728	CcSEcCtD
Isradipine—Anaphylactic shock—Sorafenib—liver cancer	0.00452	0.00714	CcSEcCtD
Isradipine—Shock—Sorafenib—liver cancer	0.00444	0.00702	CcSEcCtD
Isradipine—Fluid retention—Epirubicin—liver cancer	0.00444	0.00702	CcSEcCtD
Isradipine—Nervous system disorder—Sorafenib—liver cancer	0.00443	0.007	CcSEcCtD
Isradipine—Thrombocytopenia—Sorafenib—liver cancer	0.00442	0.00699	CcSEcCtD
Isradipine—Skin disorder—Sorafenib—liver cancer	0.00439	0.00693	CcSEcCtD
Isradipine—Nilvadipine—CYP2E1—liver cancer	0.00438	0.117	CrCbGaD
Isradipine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00411	0.0065	CcSEcCtD
Isradipine—Fluid retention—Doxorubicin—liver cancer	0.00411	0.00649	CcSEcCtD
Isradipine—Dyspnoea—Sorafenib—liver cancer	0.00403	0.00636	CcSEcCtD
Isradipine—Dyspepsia—Sorafenib—liver cancer	0.00398	0.00628	CcSEcCtD
Isradipine—Decreased appetite—Sorafenib—liver cancer	0.00393	0.0062	CcSEcCtD
Isradipine—Gastrointestinal disorder—Sorafenib—liver cancer	0.0039	0.00616	CcSEcCtD
Isradipine—Fatigue—Sorafenib—liver cancer	0.00389	0.00615	CcSEcCtD
Isradipine—Constipation—Sorafenib—liver cancer	0.00386	0.0061	CcSEcCtD
Isradipine—Amlodipine—CYP1A1—liver cancer	0.00372	0.0995	CrCbGaD
Isradipine—Urticaria—Sorafenib—liver cancer	0.00359	0.00567	CcSEcCtD
Isradipine—Cardiac failure—Epirubicin—liver cancer	0.00348	0.0055	CcSEcCtD
Isradipine—Cerebrovascular accident—Epirubicin—liver cancer	0.00347	0.00548	CcSEcCtD
Isradipine—Lethargy—Epirubicin—liver cancer	0.00347	0.00548	CcSEcCtD
Isradipine—Pain in extremity—Epirubicin—liver cancer	0.0034	0.00537	CcSEcCtD
Isradipine—Nifedipine—CYP2E1—liver cancer	0.00337	0.0902	CrCbGaD
Isradipine—Nifedipine—CYP1A1—liver cancer	0.00332	0.089	CrCbGaD
Isradipine—Nicardipine—CYP2E1—liver cancer	0.00332	0.0888	CrCbGaD
Isradipine—Asthenia—Sorafenib—liver cancer	0.00324	0.00512	CcSEcCtD
Isradipine—Cardiac failure—Doxorubicin—liver cancer	0.00322	0.00509	CcSEcCtD
Isradipine—Lethargy—Doxorubicin—liver cancer	0.00321	0.00507	CcSEcCtD
Isradipine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00321	0.00507	CcSEcCtD
Isradipine—Pruritus—Sorafenib—liver cancer	0.0032	0.00505	CcSEcCtD
Isradipine—Pain in extremity—Doxorubicin—liver cancer	0.00314	0.00497	CcSEcCtD
Isradipine—Liver function test abnormal—Epirubicin—liver cancer	0.00314	0.00495	CcSEcCtD
Isradipine—Diarrhoea—Sorafenib—liver cancer	0.00309	0.00488	CcSEcCtD
Isradipine—Breast disorder—Epirubicin—liver cancer	0.00307	0.00485	CcSEcCtD
Isradipine—Dizziness—Sorafenib—liver cancer	0.00299	0.00472	CcSEcCtD
Isradipine—Liver function test abnormal—Doxorubicin—liver cancer	0.0029	0.00458	CcSEcCtD
Isradipine—Vomiting—Sorafenib—liver cancer	0.00287	0.00454	CcSEcCtD
Isradipine—Angina pectoris—Epirubicin—liver cancer	0.00286	0.00452	CcSEcCtD
Isradipine—Rash—Sorafenib—liver cancer	0.00285	0.0045	CcSEcCtD
Isradipine—Dermatitis—Sorafenib—liver cancer	0.00285	0.0045	CcSEcCtD
Isradipine—Breast disorder—Doxorubicin—liver cancer	0.00284	0.00449	CcSEcCtD
Isradipine—Headache—Sorafenib—liver cancer	0.00283	0.00447	CcSEcCtD
Isradipine—Pollakiuria—Epirubicin—liver cancer	0.00271	0.00428	CcSEcCtD
Isradipine—Nausea—Sorafenib—liver cancer	0.00268	0.00424	CcSEcCtD
Isradipine—Photosensitivity reaction—Epirubicin—liver cancer	0.00268	0.00423	CcSEcCtD
Isradipine—Weight increased—Epirubicin—liver cancer	0.00267	0.00422	CcSEcCtD
Isradipine—Angina pectoris—Doxorubicin—liver cancer	0.00265	0.00418	CcSEcCtD
Isradipine—Drowsiness—Epirubicin—liver cancer	0.00262	0.00414	CcSEcCtD
Isradipine—Pollakiuria—Doxorubicin—liver cancer	0.00251	0.00396	CcSEcCtD
Isradipine—Photosensitivity reaction—Doxorubicin—liver cancer	0.00248	0.00392	CcSEcCtD
Isradipine—Hepatobiliary disease—Epirubicin—liver cancer	0.00248	0.00391	CcSEcCtD
Isradipine—Weight increased—Doxorubicin—liver cancer	0.00247	0.00391	CcSEcCtD
Isradipine—Drowsiness—Doxorubicin—liver cancer	0.00242	0.00383	CcSEcCtD
Isradipine—Bradycardia—Epirubicin—liver cancer	0.00239	0.00378	CcSEcCtD
Isradipine—Hepatitis—Epirubicin—liver cancer	0.00235	0.00371	CcSEcCtD
Isradipine—Hypoaesthesia—Epirubicin—liver cancer	0.00234	0.00369	CcSEcCtD
Isradipine—Urinary tract disorder—Epirubicin—liver cancer	0.00232	0.00367	CcSEcCtD
Isradipine—Oedema peripheral—Epirubicin—liver cancer	0.00231	0.00366	CcSEcCtD
Isradipine—Connective tissue disorder—Epirubicin—liver cancer	0.00231	0.00365	CcSEcCtD
Isradipine—Urethral disorder—Epirubicin—liver cancer	0.0023	0.00364	CcSEcCtD
Isradipine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00229	0.00362	CcSEcCtD
Isradipine—Visual impairment—Epirubicin—liver cancer	0.00226	0.00358	CcSEcCtD
Isradipine—Bradycardia—Doxorubicin—liver cancer	0.00221	0.0035	CcSEcCtD
Isradipine—Eye disorder—Epirubicin—liver cancer	0.0022	0.00347	CcSEcCtD
Isradipine—Cardiac disorder—Epirubicin—liver cancer	0.00218	0.00345	CcSEcCtD
Isradipine—Flushing—Epirubicin—liver cancer	0.00218	0.00345	CcSEcCtD
Isradipine—Hepatitis—Doxorubicin—liver cancer	0.00217	0.00343	CcSEcCtD
Isradipine—Hypoaesthesia—Doxorubicin—liver cancer	0.00216	0.00342	CcSEcCtD
Isradipine—Urinary tract disorder—Doxorubicin—liver cancer	0.00215	0.00339	CcSEcCtD
Isradipine—Oedema peripheral—Doxorubicin—liver cancer	0.00214	0.00338	CcSEcCtD
Isradipine—Connective tissue disorder—Doxorubicin—liver cancer	0.00214	0.00338	CcSEcCtD
Isradipine—Angiopathy—Epirubicin—liver cancer	0.00213	0.00337	CcSEcCtD
Isradipine—Urethral disorder—Doxorubicin—liver cancer	0.00213	0.00337	CcSEcCtD
Isradipine—Immune system disorder—Epirubicin—liver cancer	0.00212	0.00335	CcSEcCtD
Isradipine—Mediastinal disorder—Epirubicin—liver cancer	0.00212	0.00335	CcSEcCtD
Isradipine—Visual impairment—Doxorubicin—liver cancer	0.00209	0.00331	CcSEcCtD
Isradipine—Mental disorder—Epirubicin—liver cancer	0.00206	0.00325	CcSEcCtD
Isradipine—Malnutrition—Epirubicin—liver cancer	0.00205	0.00323	CcSEcCtD
Isradipine—Eye disorder—Doxorubicin—liver cancer	0.00203	0.00321	CcSEcCtD
Isradipine—Cardiac disorder—Doxorubicin—liver cancer	0.00202	0.00319	CcSEcCtD
Isradipine—Flushing—Doxorubicin—liver cancer	0.00202	0.00319	CcSEcCtD
Isradipine—Tension—Epirubicin—liver cancer	0.00201	0.00317	CcSEcCtD
Isradipine—Nervousness—Epirubicin—liver cancer	0.00199	0.00314	CcSEcCtD
Isradipine—Back pain—Epirubicin—liver cancer	0.00198	0.00313	CcSEcCtD
Isradipine—Angiopathy—Doxorubicin—liver cancer	0.00197	0.00312	CcSEcCtD
Isradipine—Muscle spasms—Epirubicin—liver cancer	0.00197	0.00311	CcSEcCtD
Isradipine—Immune system disorder—Doxorubicin—liver cancer	0.00196	0.0031	CcSEcCtD
Isradipine—Mediastinal disorder—Doxorubicin—liver cancer	0.00196	0.0031	CcSEcCtD
Isradipine—Vision blurred—Epirubicin—liver cancer	0.00193	0.00305	CcSEcCtD
Isradipine—Mental disorder—Doxorubicin—liver cancer	0.0019	0.00301	CcSEcCtD
Isradipine—Ill-defined disorder—Epirubicin—liver cancer	0.0019	0.003	CcSEcCtD
Isradipine—Malnutrition—Doxorubicin—liver cancer	0.00189	0.00299	CcSEcCtD
Isradipine—Anaemia—Epirubicin—liver cancer	0.00189	0.00299	CcSEcCtD
Isradipine—Tension—Doxorubicin—liver cancer	0.00186	0.00293	CcSEcCtD
Isradipine—Malaise—Epirubicin—liver cancer	0.00184	0.00291	CcSEcCtD
Isradipine—Nervousness—Doxorubicin—liver cancer	0.00184	0.0029	CcSEcCtD
Isradipine—Syncope—Epirubicin—liver cancer	0.00183	0.0029	CcSEcCtD
Isradipine—Leukopenia—Epirubicin—liver cancer	0.00183	0.00289	CcSEcCtD
Isradipine—Back pain—Doxorubicin—liver cancer	0.00183	0.00289	CcSEcCtD
Isradipine—Muscle spasms—Doxorubicin—liver cancer	0.00182	0.00287	CcSEcCtD
Isradipine—Palpitations—Epirubicin—liver cancer	0.00181	0.00286	CcSEcCtD
Isradipine—Loss of consciousness—Epirubicin—liver cancer	0.0018	0.00284	CcSEcCtD
Isradipine—Cough—Epirubicin—liver cancer	0.00178	0.00282	CcSEcCtD
Isradipine—Vision blurred—Doxorubicin—liver cancer	0.00178	0.00282	CcSEcCtD
Isradipine—Ill-defined disorder—Doxorubicin—liver cancer	0.00176	0.00277	CcSEcCtD
Isradipine—Anaemia—Doxorubicin—liver cancer	0.00175	0.00276	CcSEcCtD
Isradipine—Arthralgia—Epirubicin—liver cancer	0.00174	0.00275	CcSEcCtD
Isradipine—Chest pain—Epirubicin—liver cancer	0.00174	0.00275	CcSEcCtD
Isradipine—Anxiety—Epirubicin—liver cancer	0.00174	0.00274	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00173	0.00273	CcSEcCtD
Isradipine—Discomfort—Epirubicin—liver cancer	0.00172	0.00272	CcSEcCtD
Isradipine—Malaise—Doxorubicin—liver cancer	0.00171	0.0027	CcSEcCtD
Isradipine—Dry mouth—Epirubicin—liver cancer	0.0017	0.00269	CcSEcCtD
Isradipine—Syncope—Doxorubicin—liver cancer	0.0017	0.00268	CcSEcCtD
Isradipine—Leukopenia—Doxorubicin—liver cancer	0.00169	0.00268	CcSEcCtD
Isradipine—Palpitations—Doxorubicin—liver cancer	0.00167	0.00264	CcSEcCtD
Isradipine—Anaphylactic shock—Epirubicin—liver cancer	0.00167	0.00264	CcSEcCtD
Isradipine—Oedema—Epirubicin—liver cancer	0.00167	0.00264	CcSEcCtD
Isradipine—Loss of consciousness—Doxorubicin—liver cancer	0.00166	0.00263	CcSEcCtD
Isradipine—Cough—Doxorubicin—liver cancer	0.00165	0.00261	CcSEcCtD
Isradipine—Shock—Epirubicin—liver cancer	0.00164	0.00259	CcSEcCtD
Isradipine—Nervous system disorder—Epirubicin—liver cancer	0.00164	0.00259	CcSEcCtD
Isradipine—Thrombocytopenia—Epirubicin—liver cancer	0.00163	0.00258	CcSEcCtD
Isradipine—Tachycardia—Epirubicin—liver cancer	0.00163	0.00257	CcSEcCtD
Isradipine—Skin disorder—Epirubicin—liver cancer	0.00162	0.00256	CcSEcCtD
Isradipine—Hyperhidrosis—Epirubicin—liver cancer	0.00161	0.00255	CcSEcCtD
Isradipine—Chest pain—Doxorubicin—liver cancer	0.00161	0.00255	CcSEcCtD
Isradipine—Arthralgia—Doxorubicin—liver cancer	0.00161	0.00255	CcSEcCtD
Isradipine—Anxiety—Doxorubicin—liver cancer	0.00161	0.00254	CcSEcCtD
Isradipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.0016	0.00253	CcSEcCtD
Isradipine—Discomfort—Doxorubicin—liver cancer	0.00159	0.00252	CcSEcCtD
Isradipine—Dry mouth—Doxorubicin—liver cancer	0.00158	0.00249	CcSEcCtD
Isradipine—Hypotension—Epirubicin—liver cancer	0.00156	0.00246	CcSEcCtD
Isradipine—Anaphylactic shock—Doxorubicin—liver cancer	0.00154	0.00244	CcSEcCtD
Isradipine—Oedema—Doxorubicin—liver cancer	0.00154	0.00244	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00152	0.0024	CcSEcCtD
Isradipine—Shock—Doxorubicin—liver cancer	0.00152	0.0024	CcSEcCtD
Isradipine—Nervous system disorder—Doxorubicin—liver cancer	0.00151	0.00239	CcSEcCtD
Isradipine—Thrombocytopenia—Doxorubicin—liver cancer	0.00151	0.00239	CcSEcCtD
Isradipine—Insomnia—Epirubicin—liver cancer	0.00151	0.00239	CcSEcCtD
Isradipine—Tachycardia—Doxorubicin—liver cancer	0.00151	0.00238	CcSEcCtD
Isradipine—Skin disorder—Doxorubicin—liver cancer	0.0015	0.00237	CcSEcCtD
Isradipine—Paraesthesia—Epirubicin—liver cancer	0.0015	0.00237	CcSEcCtD
Isradipine—Hyperhidrosis—Doxorubicin—liver cancer	0.00149	0.00236	CcSEcCtD
Isradipine—Dyspnoea—Epirubicin—liver cancer	0.00149	0.00235	CcSEcCtD
Isradipine—Somnolence—Epirubicin—liver cancer	0.00148	0.00234	CcSEcCtD
Isradipine—Dyspepsia—Epirubicin—liver cancer	0.00147	0.00232	CcSEcCtD
Isradipine—Decreased appetite—Epirubicin—liver cancer	0.00145	0.00229	CcSEcCtD
Isradipine—Hypotension—Doxorubicin—liver cancer	0.00144	0.00228	CcSEcCtD
Isradipine—Gastrointestinal disorder—Epirubicin—liver cancer	0.00144	0.00228	CcSEcCtD
Isradipine—Fatigue—Epirubicin—liver cancer	0.00144	0.00227	CcSEcCtD
Isradipine—Constipation—Epirubicin—liver cancer	0.00143	0.00226	CcSEcCtD
Isradipine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00141	0.00222	CcSEcCtD
Isradipine—Insomnia—Doxorubicin—liver cancer	0.0014	0.00221	CcSEcCtD
Isradipine—Paraesthesia—Doxorubicin—liver cancer	0.00139	0.00219	CcSEcCtD
Isradipine—Dyspnoea—Doxorubicin—liver cancer	0.00138	0.00218	CcSEcCtD
Isradipine—Feeling abnormal—Epirubicin—liver cancer	0.00138	0.00217	CcSEcCtD
Isradipine—Somnolence—Doxorubicin—liver cancer	0.00137	0.00217	CcSEcCtD
Isradipine—Dyspepsia—Doxorubicin—liver cancer	0.00136	0.00215	CcSEcCtD
Isradipine—Decreased appetite—Doxorubicin—liver cancer	0.00134	0.00212	CcSEcCtD
Isradipine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00133	0.00211	CcSEcCtD
Isradipine—Fatigue—Doxorubicin—liver cancer	0.00133	0.0021	CcSEcCtD
Isradipine—Urticaria—Epirubicin—liver cancer	0.00133	0.0021	CcSEcCtD
Isradipine—Constipation—Doxorubicin—liver cancer	0.00132	0.00209	CcSEcCtD
Isradipine—Feeling abnormal—Doxorubicin—liver cancer	0.00127	0.00201	CcSEcCtD
Isradipine—Urticaria—Doxorubicin—liver cancer	0.00123	0.00194	CcSEcCtD
Isradipine—Asthenia—Epirubicin—liver cancer	0.0012	0.00189	CcSEcCtD
Isradipine—Pruritus—Epirubicin—liver cancer	0.00118	0.00187	CcSEcCtD
Isradipine—Diarrhoea—Epirubicin—liver cancer	0.00114	0.0018	CcSEcCtD
Isradipine—Asthenia—Doxorubicin—liver cancer	0.00111	0.00175	CcSEcCtD
Isradipine—Dizziness—Epirubicin—liver cancer	0.0011	0.00174	CcSEcCtD
Isradipine—Pruritus—Doxorubicin—liver cancer	0.00109	0.00173	CcSEcCtD
Isradipine—Vomiting—Epirubicin—liver cancer	0.00106	0.00168	CcSEcCtD
Isradipine—Diarrhoea—Doxorubicin—liver cancer	0.00106	0.00167	CcSEcCtD
Isradipine—Rash—Epirubicin—liver cancer	0.00105	0.00166	CcSEcCtD
Isradipine—Dermatitis—Epirubicin—liver cancer	0.00105	0.00166	CcSEcCtD
Isradipine—Headache—Epirubicin—liver cancer	0.00105	0.00165	CcSEcCtD
Isradipine—Dizziness—Doxorubicin—liver cancer	0.00102	0.00161	CcSEcCtD
Isradipine—Nausea—Epirubicin—liver cancer	0.000991	0.00157	CcSEcCtD
Isradipine—Vomiting—Doxorubicin—liver cancer	0.000982	0.00155	CcSEcCtD
Isradipine—Rash—Doxorubicin—liver cancer	0.000974	0.00154	CcSEcCtD
Isradipine—Dermatitis—Doxorubicin—liver cancer	0.000973	0.00154	CcSEcCtD
Isradipine—Headache—Doxorubicin—liver cancer	0.000968	0.00153	CcSEcCtD
Isradipine—Nausea—Doxorubicin—liver cancer	0.000917	0.00145	CcSEcCtD
Isradipine—CACNA1D—Metabolism—GSTA4—liver cancer	0.00043	0.00131	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—RAF1—liver cancer	0.000428	0.0013	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000428	0.0013	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GOT2—liver cancer	0.000427	0.0013	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTA1—liver cancer	0.000427	0.0013	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—MMP9—liver cancer	0.000424	0.00129	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000423	0.00128	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KDR—liver cancer	0.000423	0.00128	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—NAT2—liver cancer	0.000423	0.00128	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NR1H4—liver cancer	0.000421	0.00128	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—RAF1—liver cancer	0.00042	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MAPK14—liver cancer	0.00042	0.00127	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTA2—liver cancer	0.000419	0.00127	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000417	0.00127	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MET—liver cancer	0.000414	0.00126	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTA3—liver cancer	0.000413	0.00125	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—RAF1—liver cancer	0.000406	0.00123	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALDOB—liver cancer	0.000405	0.00123	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTA1—liver cancer	0.000405	0.00123	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP2—liver cancer	0.000403	0.00122	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP2—liver cancer	0.000403	0.00122	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP2E1—liver cancer	0.000402	0.00122	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KDR—liver cancer	0.000401	0.00121	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—NAT2—liver cancer	0.0004	0.00121	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MAPK14—liver cancer	0.000398	0.00121	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MET—liver cancer	0.000392	0.00119	CbGpPWpGaD
Isradipine—CACNA2D2—Neuronal System—HRAS—liver cancer	0.000388	0.00118	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CRABP1—liver cancer	0.000386	0.00117	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALDOB—liver cancer	0.000384	0.00116	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—KRAS—liver cancer	0.000382	0.00116	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—VEGFA—liver cancer	0.000381	0.00115	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PPARA—liver cancer	0.000379	0.00115	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTA4—liver cancer	0.000378	0.00115	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—PPARG—liver cancer	0.000376	0.00114	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYCS—liver cancer	0.000376	0.00114	CbGpPWpGaD
Isradipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000373	0.00113	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GGT1—liver cancer	0.000369	0.00112	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GOT1—liver cancer	0.000369	0.00112	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTA2—liver cancer	0.000369	0.00112	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CRABP1—liver cancer	0.000366	0.00111	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—CTNNB1—liver cancer	0.000364	0.0011	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—MMP9—liver cancer	0.000364	0.0011	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—MMP9—liver cancer	0.000357	0.00108	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—RAF1—liver cancer	0.000357	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—RAF1—liver cancer	0.000357	0.00108	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—PPARG—liver cancer	0.000356	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTA1—liver cancer	0.000356	0.00108	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000355	0.00108	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KDR—liver cancer	0.000352	0.00107	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—NAT2—liver cancer	0.000352	0.00107	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MAPK14—liver cancer	0.00035	0.00106	CbGpPWpGaD
Isradipine—CACNB2—Transmission across Chemical Synapses—HRAS—liver cancer	0.000347	0.00105	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP2—liver cancer	0.000345	0.00105	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MET—liver cancer	0.000344	0.00104	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—MMP9—liver cancer	0.000344	0.00104	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000338	0.00103	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HPGDS—liver cancer	0.000338	0.00102	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALDOB—liver cancer	0.000337	0.00102	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTP1—liver cancer	0.000331	0.001	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP2—liver cancer	0.000327	0.000991	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—HMOX1—liver cancer	0.000327	0.000991	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—VEGFA—liver cancer	0.000327	0.00099	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—HRAS—liver cancer	0.000324	0.000984	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—KRAS—liver cancer	0.000324	0.000982	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CRABP1—liver cancer	0.000322	0.000975	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—VEGFA—liver cancer	0.00032	0.000971	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HPGDS—liver cancer	0.00032	0.00097	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—STAT3—liver cancer	0.000317	0.000962	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—PPARG—liver cancer	0.000313	0.000949	CbGpPWpGaD
Isradipine—CACNA1H—Axon guidance—IL6—liver cancer	0.00031	0.000941	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—VEGFA—liver cancer	0.000309	0.000938	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—CTNNB1—liver cancer	0.000309	0.000936	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—RAF1—liver cancer	0.000306	0.000927	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—GSTM1—liver cancer	0.000304	0.000923	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—MMP9—liver cancer	0.000303	0.000918	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—MMP9—liver cancer	0.000303	0.000918	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PSMA4—liver cancer	0.000301	0.000913	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PSMD10—liver cancer	0.000301	0.000913	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TGFB1—liver cancer	0.000294	0.000891	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GOT2—liver cancer	0.000293	0.000888	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—RAF1—liver cancer	0.00029	0.000878	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—CYP1A1—liver cancer	0.000289	0.000875	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP2—liver cancer	0.000287	0.000871	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PSMA4—liver cancer	0.000285	0.000865	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PSMD10—liver cancer	0.000285	0.000865	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HPGDS—liver cancer	0.000281	0.000852	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—KRAS—liver cancer	0.000278	0.000842	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GOT2—liver cancer	0.000277	0.000841	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000276	0.000836	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP2E1—liver cancer	0.000275	0.000835	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—HRAS—liver cancer	0.000275	0.000835	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—TNF—liver cancer	0.000275	0.000832	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—KRAS—liver cancer	0.000272	0.000826	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000272	0.000825	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—VEGFA—liver cancer	0.000272	0.000824	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—VEGFA—liver cancer	0.000272	0.000824	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—STAT3—liver cancer	0.000269	0.000816	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—MTHFR—liver cancer	0.000269	0.000816	CbGpPWpGaD
Isradipine—CACNB2—Neuronal System—HRAS—liver cancer	0.000266	0.000806	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—CTNNB1—liver cancer	0.000265	0.000803	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PPARA—liver cancer	0.000264	0.000801	CbGpPWpGaD
Isradipine—CACNA1S—Axon guidance—IL6—liver cancer	0.000263	0.000799	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—KRAS—liver cancer	0.000263	0.000797	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP2E1—liver cancer	0.000261	0.000791	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—MMP9—liver cancer	0.000259	0.000787	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYCS—liver cancer	0.000258	0.000781	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—RAF1—liver cancer	0.000254	0.000772	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000253	0.000768	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GGT1—liver cancer	0.000253	0.000767	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GOT1—liver cancer	0.000253	0.000767	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—CTNNB1—liver cancer	0.000251	0.00076	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PSMA4—liver cancer	0.000251	0.00076	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PSMD10—liver cancer	0.000251	0.00076	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TGFB1—liver cancer	0.000249	0.000756	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—MMP9—liver cancer	0.000246	0.000745	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYCS—liver cancer	0.000244	0.00074	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GOT2—liver cancer	0.000244	0.000739	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GOT1—liver cancer	0.000239	0.000726	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GGT1—liver cancer	0.000239	0.000726	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—HRAS—liver cancer	0.000236	0.000715	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—VEGFA—liver cancer	0.000233	0.000707	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—TNF—liver cancer	0.000233	0.000706	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—HRAS—liver cancer	0.000231	0.000702	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—KRAS—liver cancer	0.000231	0.000701	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—KRAS—liver cancer	0.000231	0.0007	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—STAT3—liver cancer	0.000231	0.0007	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP2E1—liver cancer	0.000229	0.000695	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000227	0.00069	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTP1—liver cancer	0.000227	0.000689	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CG—liver cancer	0.000226	0.000686	CbGpPWpGaD
Isradipine—CACNB2—Axon guidance—IL6—liver cancer	0.000226	0.000685	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000224	0.00068	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—HMOX1—liver cancer	0.000224	0.000679	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—HRAS—liver cancer	0.000223	0.000678	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—IL6—liver cancer	0.000222	0.000672	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—VEGFA—liver cancer	0.000221	0.000669	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—CTNNB1—liver cancer	0.00022	0.000668	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—STAT3—liver cancer	0.000218	0.000663	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PPARG—liver cancer	0.000218	0.000662	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—MMP9—liver cancer	0.000216	0.000655	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTP1—liver cancer	0.000215	0.000652	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYCS—liver cancer	0.000214	0.00065	CbGpPWpGaD
Isradipine—CACNA1D—Axon guidance—IL6—liver cancer	0.000214	0.000649	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TGFB1—liver cancer	0.000214	0.000649	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—HMOX1—liver cancer	0.000212	0.000643	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GGT1—liver cancer	0.00021	0.000638	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GOT1—liver cancer	0.00021	0.000638	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000209	0.000634	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—GSTM1—liver cancer	0.000209	0.000633	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000206	0.000625	CbGpPWpGaD
Isradipine—CACNA1H—Developmental Biology—AKT1—liver cancer	0.000204	0.00062	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TGFB1—liver cancer	0.000203	0.000614	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—TNF—liver cancer	0.0002	0.000606	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CD—liver cancer	0.000199	0.000603	CbGpPWpGaD
Isradipine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000198	0.000601	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—KRAS—liver cancer	0.000198	0.000601	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—CYP1A1—liver cancer	0.000198	0.0006	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—GSTM1—liver cancer	0.000198	0.000599	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—HRAS—liver cancer	0.000196	0.000596	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—HRAS—liver cancer	0.000196	0.000595	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—ALB—liver cancer	0.000196	0.000595	CbGpPWpGaD
Isradipine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000195	0.000592	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—VEGFA—liver cancer	0.000194	0.000588	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—STAT3—liver cancer	0.000192	0.000582	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—TNF—liver cancer	0.000189	0.000573	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTP1—liver cancer	0.000189	0.000573	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—IL6—liver cancer	0.000188	0.00057	CbGpPWpGaD
Isradipine—CACNA1C—Axon guidance—IL6—liver cancer	0.000188	0.00057	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—KRAS—liver cancer	0.000188	0.000569	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—CYP1A1—liver cancer	0.000187	0.000568	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—HMOX1—liver cancer	0.000186	0.000565	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—MTHFR—liver cancer	0.000184	0.000559	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PPARA—liver cancer	0.000181	0.000549	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TGFB1—liver cancer	0.000178	0.00054	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—MTHFR—liver cancer	0.000175	0.00053	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—GSTM1—liver cancer	0.000174	0.000527	CbGpPWpGaD
Isradipine—CACNA1S—Developmental Biology—AKT1—liver cancer	0.000173	0.000526	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CB—liver cancer	0.000173	0.000525	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PPARA—liver cancer	0.000171	0.00052	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—HRAS—liver cancer	0.000168	0.000511	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—TNF—liver cancer	0.000166	0.000504	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—KRAS—liver cancer	0.000165	0.0005	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—CYP1A1—liver cancer	0.000165	0.000499	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—IL6—liver cancer	0.000161	0.000489	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—HRAS—liver cancer	0.000159	0.000484	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CG—liver cancer	0.000155	0.00047	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—MTHFR—liver cancer	0.000153	0.000465	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—IL6—liver cancer	0.000153	0.000463	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PPARA—liver cancer	0.000151	0.000457	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PPARG—liver cancer	0.00015	0.000454	CbGpPWpGaD
Isradipine—CACNB2—Developmental Biology—AKT1—liver cancer	0.000149	0.000451	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—UGDH—liver cancer	0.000148	0.000449	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CG—liver cancer	0.000147	0.000445	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PPARG—liver cancer	0.000142	0.000429	CbGpPWpGaD
Isradipine—CACNA1D—Developmental Biology—AKT1—liver cancer	0.000141	0.000427	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—HRAS—liver cancer	0.00014	0.000425	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—EPT1—liver cancer	0.000139	0.000422	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CD—liver cancer	0.000136	0.000413	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—ALB—liver cancer	0.000134	0.000408	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—IL6—liver cancer	0.000134	0.000407	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—TAT—liver cancer	0.000132	0.0004	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CD—liver cancer	0.000129	0.000391	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CG—liver cancer	0.000129	0.000391	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—ALB—liver cancer	0.000127	0.000386	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PPARG—liver cancer	0.000124	0.000377	CbGpPWpGaD
Isradipine—CACNA1C—Developmental Biology—AKT1—liver cancer	0.000124	0.000375	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CB—liver cancer	0.000119	0.00036	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CD—liver cancer	0.000113	0.000344	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CB—liver cancer	0.000112	0.000341	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—ALB—liver cancer	0.000112	0.000339	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—PIK3CA—liver cancer	0.000106	0.00032	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CB—liver cancer	9.88e-05	0.0003	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CPT1B—liver cancer	8.98e-05	0.000272	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GLUL—liver cancer	8.98e-05	0.000272	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NR1H4—liver cancer	8.66e-05	0.000262	CbGpPWpGaD
Isradipine—CACNA2D2—Metabolism—AKT1—liver cancer	8.63e-05	0.000262	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA3—liver cancer	8.51e-05	0.000258	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA4—liver cancer	7.78e-05	0.000236	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA2—liver cancer	7.58e-05	0.00023	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTA1—liver cancer	7.32e-05	0.000222	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—PIK3CA—liver cancer	7.24e-05	0.000219	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—NAT2—liver cancer	7.24e-05	0.000219	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALDOB—liver cancer	6.94e-05	0.00021	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—PIK3CA—liver cancer	6.85e-05	0.000208	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CRABP1—liver cancer	6.62e-05	0.000201	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—PIK3CA—liver cancer	6.02e-05	0.000183	CbGpPWpGaD
Isradipine—CACNB2—Metabolism—AKT1—liver cancer	5.91e-05	0.000179	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HPGDS—liver cancer	5.78e-05	0.000175	CbGpPWpGaD
Isradipine—CACNA1D—Metabolism—AKT1—liver cancer	5.6e-05	0.00017	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PSMA4—liver cancer	5.16e-05	0.000156	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PSMD10—liver cancer	5.16e-05	0.000156	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GOT2—liver cancer	5.02e-05	0.000152	CbGpPWpGaD
Isradipine—CACNA1C—Metabolism—AKT1—liver cancer	4.92e-05	0.000149	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP2E1—liver cancer	4.72e-05	0.000143	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYCS—liver cancer	4.41e-05	0.000134	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GGT1—liver cancer	4.33e-05	0.000131	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GOT1—liver cancer	4.33e-05	0.000131	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTP1—liver cancer	3.89e-05	0.000118	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—HMOX1—liver cancer	3.84e-05	0.000116	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—GSTM1—liver cancer	3.57e-05	0.000108	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.39e-05	0.000103	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—MTHFR—liver cancer	3.16e-05	9.58e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPARA—liver cancer	3.1e-05	9.4e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CG—liver cancer	2.65e-05	8.05e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PPARG—liver cancer	2.56e-05	7.77e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.33e-05	7.07e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—ALB—liver cancer	2.3e-05	6.98e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.03e-05	6.17e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.24e-05	3.76e-05	CbGpPWpGaD
Isradipine—CYP3A4—Metabolism—AKT1—liver cancer	1.01e-05	3.07e-05	CbGpPWpGaD
